Famed investor Jim Cramer warns against investing in Marvell Technology Inc (NQ: MRVL) even though it’s down over 10% on Friday. Cramer shares view on Marvell stockThe $66 billion chipmaker based out of Wilmington, Delaware posted an in-line earnings report Thursday night but disappointed in terms of guidance.MRVL also authorised $3.0 billion in stock repurchase this week; but Cramer remains dovish on the semiconductor giant as there still are things that “haven’t troughed [and] are going down”.“Stock-based compensation” also contributed to his view that “it’s too soon to buy” Marvell stock.Note that his Charitable Trust did use to have a position in the Nasdaq-listed firm and it’s still in his Club’s Bullpen stock watchlist as well.The Mad Money host is dovish on Marvell Technology even though it recently announced the “industry’s first” 2-nanometre platform for “accelerated infrastructure”.Elsewhere, Citi analyst Atif Malik raised the price target for MRVL to $91 (20% higher than Friday’s close).More By This Author:Costco’s Stock Tumbles After Earnings Miss: Analysts Weigh In On COST’s Future Coinbase Crashes Again, Third Episode In Recent Weeks Dogecoin Price Forecast: Analyst Predicts Surge To $1 By Mid-April
Top Entertainment
Search
New Posts
These fungi drug cicadas with psilocybin or amphetamine to make them mate nonstop
Chronic asthma could be caused by cell overcrowding in the airways
These fungi drug cicadas with psilocybin or amphetamine to make them mate nonstop
Chronic asthma could be caused by cell overcrowding in the airways
These fungi drug cicadas with psilocybin or amphetamine to make them mate nonstop
Leave A Comment